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VIP21-caveolin is a membrane protein, proposed to be a component of the striated coat
covering the cytoplasmic surface of caveolae. To investigate the biochemical composition
of the caveolar coat, we used our previous observation that VIP21-caveolin is present in
large complexes and insoluble in the detergents CHAPS or Triton X-114. The mild
treatment of these insoluble structures with sodium dodecyl sulfate leads to the detection
of high molecular mass complexes of approximately 200, 400, and 600 kDa. The 400-kDa
complex purified to homogeneity from dog lung is shown to consist exclusive of the two
isoforms of VIP21-caveolin. Pulse-chase experiments indicate that the oligomers form
early after the protein is synthesized in the endoplasmic reticulum (ER). VIP21-caveolin
does indeed insert into the ER membrane through the classical translocation machinery.
Its hydrophobic domain adopts an unusual loop configuration exposing the N- and
C-flanking regions to the cytoplasm. Similar high molecular mass complexes can be
produced from the in vitro-synthesized VIP21-caveolin. The complex formation occurs
only if VIP21-caveolin isoforms are properly inserted into the membrane; formation is
cytosol-dependent and does not involve a vesicle fusion step. We propose that high
molecular mass oligomers of VIP21-caveolin represent the basic units forming the caveo-
lar coat. They are formed in the ER and later, between the ER and the plasma membrane,
these oligomers could associate into larger detergent-insoluble structures.
INTRODUCTION
Caveolae or plasmalemmal vesicles are nonclathrin-
coated membrane invaginations that are found on the
plasma membrane of almost all types of cells (for
reviews see Anderson, 1993a; Anderson et al., 1992;
and references therein). Using various electron micro-
scopic techniques, it has been possible to visualize the
fine caveolar structure (Montesano et al., 1982; Peters
et al., 1985; Anderson, 1991; Steer and Heuser, 1991;
Rothberg et al., 1992). On the cytoplasmic surface,
multiple filaments can be seen wrapped around the
invaginated plasma membrane. When viewed en face
these filaments appear as a striated coat.
* Corresponding author.
The function of caveolae is still uncertain although
several possibilities have been postulated, including
an alternative pathway of endocytosis (Montesano et
al., 1982; Simionescu et al., 1982; Tran et al., 1987);
transcytosis (Ghitescu et al., 1986); receptor-mediated
uptake of small molecules (potocytosis; Rothberg et al.,
1990; Anderson et al., 1992); intracellular calcium con-
centration regulation (Fujimoto, 1993; Fujimoto et al.,
1993); and signal transduction (Anderson, 1993b; Sar-
giacomo et al., 1993; Lisanti et al., 1994a).
The investigation of caveolae was greatly enhanced
by the identification of a caveolar protein marker.
Antibodies against a protein of 22 kDa, which was
initially identified as one of the main substrates of src
kinase in v-src-transformed cells (Glenney, 1989;
Glenney and Zokas, 1989), decorated the caveolar fil-
aments (Rothberg et al., 1992). The protein was termed
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caveolin and was suggested to be a component of the
coat material (Rothberg et al., 1992). The chicken
caveolin is almost identical to canine VIP21 (vesicular
integral membrane protein of 21 kDa) (Glenney, 1992;
Glenney and Soppet, 1992). The latter protein was
identified through research on protein sorting in po-
larized epithelial cells as a constituent of trans-Golgi-
derived vesicles (Kurzchalia et al., 1992). VIP21-caveo-
lin is an integral membrane protein: it cannot be
extracted from membranes by either high salt or car-
bonate treatment (Dupree et al., 1993). Subsequently,
VIP21 was also localized to caveolae and the trans-
Golgi-network (TGN)l (Dupree et al., 1993).
Apart from the localization of VIP21-caveolin to
caveolae, very little is known about the coat constitu-
ents (e.g. interaction partners of VIP21-caveolin) or the
mechanisms governing the formation of caveolar fila-
ments. In this respect, the fact that VIP21-caveolin is
not solubilized by detergents such as 3-[(3-cholamido-
propyl)-dimethylammonio]-l-propane sulfonate
(CHAPS) or Triton X-100 could be a useful tool. VIP21-
caveolin was one of the proteins found in detergent-
insoluble structures together with an apically destined
integral membrane protein, influenza hemagglutinin
(HA), after treatment of TGN-derived vesicles iso-
lated from Madin-Darby canine kidney (MDCK) cells
with detergents (Kurzchalia et al., 1992). Also, glyco-
sylphosphatidyl-inositol (GPI)-anchored proteins,
which according to morphological studies concentrate
in caveolae (Rothberg et al., 1990), were found in a
Triton-insoluble floating fraction (later referred to as
TIFF) (Hoessli and Rungger-Brandle, 1985; Brown and
Rose, 1992). TIFF, like caveolae, is enriched in choles-
terol and glycosphingolipids (Montesano et al., 1982;
Rothberg et al., 1990; Brown and Rose, 1992; Fiedler et
al., 1993; Parton, 1994). All together, these data led to
the hypothesis that TIFF is similar, if not identical, to
caveolae (Lisanti et al., 1993; Sargiacomo et al., 1993).
Recently, some of these proteins have been identified
(Arreaza et al., 1994; Chang et al., 1994; Fiedler et al.,
1994; Lisanti et al., 1994b). These proteins, including
the src kinases, rab proteins, the thrombospondin re-
ceptor (CD36), gelsolin, and even albumin, have very
different structures and a wide range of functions. It is
likely that the detergent-insoluble material is derived
from various intracellular membranes, including the
TGN and caveolar membrane domains. Because of
their biochemical nature, some proteins become in-
cluded in this material but obviously have nothing to
1 Abbreviations used: 2D, two dimensional; DPM, dog pancreas
microsomes; ER, endoplasmic reticulum; GH, growth hormone;
GPI, glycosylphosphatidyl-inositol; GS, glycosylation site; SRP,
signal recognition particle; TGN, trans-Golgi network; TIFF, Triton-
insoluble floating fraction; TR VIP, truncated form of VIP21-caveo-
lin, deleted of its first 31 amino acids; WT VIP, wild-type VIP21-
caveolin.
do with caveolae. Therefore, the localization of each
protein identified in the detergent-insoluble material
and its interaction with VIP21-caveolin must be inves-
tigated carefully.
The study of biochemical properties of VIP21-caveo-
lin is very important in terms of vesicular transport.
There must be fundamental differences between for-
mation of clathrin or COP-containing vesicular coats
on the one hand and the caveolar coat on the other.
The first two consist almost entirely of soluble proteins
whereas VIP21-caveolin is an integral membrane pro-
tein. Obviously, the cellular location of the VIP21-
caveolin insertion into the membrane and its mem-
brane topology should directly influence interaction of
VIP21-caveolin with other caveolar proteins and the
formation of the caveolar filaments. For instance, the
topology of VIP21-caveolin could have an implication
on its interaction with GPI-anchored proteins. There is
still controversy concerning whether both N- and C-
domains of VIP21-caveolin are facing the cytoplasm
(Dupree et al., 1993), or if VIP21-caveolin is a type II
membrane protein with its C-terminus exposed to the
outside of the cell (Sargiacomo et al., 1993). A direct
interaction between VIP21-caveolin and the polypep-
tide chain of a GPI-anchored protein would occur only
if the second orientation is correct.
To address some of the problems mentioned above,
we have studied the biosynthetic pathway of VIP21-
caveolin, its membrane topology, and properties of the
VIP21-caveolin-containing complexes in detail.
MATERIALS AND METHODS
Materials
Detergents were purchased from Calbiochem (San Diego, CA). Re-
agents for SDS-polyacrylamide gel electrophoresis (PAGE) were
obtained from ICN (Meckenheim, Germany). Nitrocellulose filter-
paper was obtained from Schleicher & Schuell (Dassel, Germany);
protein-A sepharose was obtained from Pharmacia (Upsala, Swe-
den) or from Sigma (Deisenhofen, Germany). The chemilumines-
cence-detection kit (ECL) and [35S]methionine were obtained from
Amersham (Buckinghamshire, UK); proteinase K, chymotrypsin,
and endoglycosidase F were obtained from Boehringer (Mannheim,
Germany). Trypsin was obtained from Promega (Heidelberg, Ger-
many). The protein marker kit for very high molecular weights,
brefeldin A, aprotinin, and phenylmethylsulfonyl fluoride (PMSF)
were obtained from Sigma (Deisenhofen, Germany). The cell culture
medium, reagents, and Geneticin (G418) were obtained from Life
Technologies (Eggenstein, Germany); the cell culture dishes were
obtained from Nunc (Roskilde, Denmark). The reagents used for
cDNA cloning, for in vitro transcription, translation, and transloca-
tion were obtained from the sources described in Monier et al.
(1988). The rabbit polyclonal antibody directed against the N-region
(amino acids 14-33) (VIP21-N) was a gift from Dr. Paul Dupree
(University of Cambridge, UK). HeLa cells were a gift from Dr. Bill
Dolan (New York University Medical Center, New York, NY).
Preparation of CHAPS Complex from Total Cell
Membrane Fraction
For analytical purposes, the CHAPS complex was prepared from
MDCK cells as previously described (Kurzchalia et al., 1992; Fiedler
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et al., 1993) with the following modification. Instead of a flotation
gradient, the post nuclear supematant was centrifuged at 100,000 X
g for 1 h. The resulting microsomal pellet was treated with 20 mM
CHAPS at 4°C and spun on a 10-30% linear sucrose gradient in a
SW40 rotor at 38,000 rpm for 2.5 h. The pellet was solubilized with
SDS-PAGE sample buffer and subjected to electrophoresis.
Preparation of TIFF from MDCK Cells and
Dog Lung
TIFF from dog lung was prepared according to a modified proce-
dure described for MDCK cells (Fiedler et al., 1993). Forty grams of
canine lung were minced and homogenized with a Potter-homog-
enizer in Hoagland buffer (50 mM Tris/HCl, pH 7.5, 25 mM KCI, 5
mM MgCl2, 0.2 mM EDTA, 250 mM sucrose, and 0.2 mM PMSF,
added fresh before homogenization). The ratio of tissue to buffer
was 1:2.5 and seven strokes at maximal rotation rate were applied.
The homogenate was centrifuged for 20 min at 10,000 x g and
filtered through a cloth. After 75 min of centrifugation at 28,000 rpm
in a Ti35 rotor, the microsomal pellet was resuspended in 7.5 ml of
250 mM sucrose in TNE (25 mM Tris/HCl, pH 7.5, 100 mM NaCl, 2
mM EDTA) containing 5mM,B-mercaptoethanol, and brought to 1.5
M sucrose in a total volume of 10 ml. The solution was overlaid by
17 ml of 1.2 M sucrose and 7 ml of 0.8 M sucrose, both sucrose
solutions containing TNE and 5 mM dithiothreitol (DTT). After
centrifugation in an SW28 rotor for 20 h at 28,000 rpm, the total
membrane fraction was collected at the 0.8/1.2 M sucrose interface.
This fraction was extracted with 1% Triton X-114 in TNE and
protease inhibitors in a total volume of 10 ml. The extract was
brought to 1.4 M sucrose, a 4-ml fraction was overlaid by 6 ml and
2 ml of 1.1 M and 0.15 M sucrose, respectively. Flotation was carried
out for 21 h at 39,000 rpm in a SW40 rotor. The opalescent interface
between 1.1 M and 0.15 M sucrose was collected (7.5 ml), diluted to
36 ml with TNE, and centrifuged in SW40 for 8 h at 39,000 rpm. The
pellets were resuspended in 1% Triton X-114 in TNE, incubated on
ice for 30 min, and brought to 1.4 M sucrose. The previous flotation
procedure was repeated and the resulting pellets were resuspended
in 18 ml of 1% Triton X-114 in TNE (TIFF).
The TIFF was heated to 37°C under permanent vortexing. After 15
min, the suspension was chilled on ice for 5 min and centrifuged for
15 min at 10,000 x g. The resulting pellet was used for high molec-
ular mass complex isolation.
Isolation of the 400-kDa Complex
The pellet (P) was resuspended in 1 ml of alkaline SDS-PAGE
sample buffer lacking bromophenol blue. For analytical purposes,
100 ml aliquots were incubated at 25°C and overlaid onto a 4 ml
10-30% linear sucrose gradient containing 0.2% SDS and TNE. The
gradients were centrifuged in a SW60 rotor at 40,000 rpm for 19 h at
19°C. Aliquots of the recovered 0.5-ml fractions were mixed with
alkaline sample buffer, incubated at 25°C, or boiled and processed
for Western blot analysis using the VIP21-N antibody.
Preparative isolation of the 400-kDa complex was performed
from 0.8 ml of the P fraction treated by 1% SDS at room temperature
and overlaid onto an 11-ml 10-30% continuous sucrose gradient.
After a 23-h centrifugation at 39,000 rpm in a SW40 rotor, 1-ml
fractions were collected, and the amount of VIP21-caveolin present
in each fraction was analyzed by Western blot analysis. The peak
fraction (1 ml) was dialyzed against TNE containing 0.2% SDS and
subjected to an identical sucrose gradient centrifugation.
Determination of an S-Value of the
400-kDa Complex
After velocity sucrose gradient centrifugation, the peak fraction
containing purified VIP21-caveolin was dialyzed against 2 x 200 ml
of buffer containing 50 mM Tris-HCl, pH 7.5, 0.2% SDS, and 50 mM
DTT. The S-value at 20°C was determined using an UV-detection
system with photoelectric scanner (Behlke et al., 1986).
Electron Microscopy
Samples of TIFF or gradient fractions were incubated on formvar-
coated grids, rinsed with detergent-free TN buffer (25mM Tris-HCl,
pH7.5, 100 mM NaCl), and then negatively stained with uranyl
acetate. For immunolabeling, grids were incubated sequentially
with affinity-purified VIP21-N antibodies and 5 nm protein A-gold
in TN buffer before negative staining. Antibodies and washing
solutions were centrifuged at maximum speed in the microfuge for
5min or filtered before use. An irrelevant antibody (affinity-purified
rabbit anti-rab2, kindly provided by Dr. Marino Zerial, EMBL,
Heidelberg), used at the same concentration as the VIP21-N, gave
no significant labeling.
SDS-PAGE and Bloffing Techniques
Most techniques were performed as previously described (Kurzcha-
lia et al., 1992). Two SDS-PAGE sample buffers were used: the
standard buffer, containing 12.5 mM Tris-HCl, pH 6.8, and the
alkaline buffer, containing 12.5 mM Tris-base (the other components
being the same for both: 2% SDS, 1% 3-mercaptoethanol, 0.00125%
bromophenol blue, and 10% glycerol). High molecular mass com-
plexes were separated on 2.5-7.5% or 2.5-16% acrylamide gradient
gels with a 2.5% or 3% stacking gel. The samples in the standard or
in the alkaline sample buffer were incubated at 25°C for 30 min or
boiled for 5 min as indicated in the legends to figures. When 2D gel
analysis was carried out, the first dimension involved the separation
of large complexes present in nonboiled samples on a 2.5-7.5%
resolving gel. Each lane was cut, boiled in a bag containing alkaline
sample buffer, and loaded on the second dimension, 3-16% resolv-
ing gel.
Cell Culture, Transfection, Radioactive Labeling,
and Immunoprecipitation Techniques
MDCK cells were grown as described in Kurzchalia et al. (1992).
HeLa cells were maintained and transfected according to Monier et
al. (1988), except that the in vivo expression vector pSV2 TKneo was
used (Compton et al., 1989). Permanent transformants were selected
by their growth in the G418-containing medium. Individual clones
were screened for overexpression of the wild-type VIP21 by immu-
noprecipitation: after overnight metabolic labeling in the presence
of 80 mCi/ml of [35S]methionine and 5 mM sodium butyrate
(Monier et al., 1988), the cells were solubilized in a lysis buffer
(Dupree et al., 1993) and the whole extract was incubated for 20 h
with the VIP21-N antibody.
Pulse-chase experiments were performed on subconfluent cul-
tures grown in 35-mm dishes. After an induction with 5 mM sodium
butyrate for 6.5 h, cells were incubated in serum-free, methionine-
free medium for 30 min, then pulse-labeled in fresh medium sup-
plemented with 150 mCi/ml of radioactive methionine for 7 min,
and chased in medium containing 10% fetal calf serum and a 30-fold
excess of cold methionine for various time points. Cells were solu-
bilized and immunoprecipitated as described above.
The brefeldin A treatment was performed according to Ivessa et
al. (1992), except that the cells were given a 10-min pulse of radio-
active methionine and further incubated in the chase medium for 1
h or 4 h before solubilization and immunoprecipitation.
Cloning Procedures
Fusion proteins containing a glycosylation site placed upstream
from the portion of rat growth hormone (GH) comprised between
amino acids 42 and 130, and various parts of VIP21, were con-
structed using the polymerase chain reaction (PCR) technique. First,
preGH was deleted of its signal peptide (amino acids 1-26) and of
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the next 15 residues (which present a relatively high hydrophobicity
and could potentially act as a signal peptide). A glycosylation site
was added at position 2 (Met Asn Gly Thr), the same site as the one
present in the opsin protein (see Monier et al., 1988). The reaction
was performed using the wild-type GH as a template, a sense 50
mer hydridizing to the 5' end of the insert and containing the
cloning site SacI, the glycosylation site including a BamHI site and a
region encoding the amino acids 42-50 of GH, and a primer com-
plementary to the vector sequence at the 3' end. The PCR product
was cloned in the SacI/PstI of pSP65 to generate pGSAGH. Second,
the PCR was performed using VIP21 cloned in the Bluescript vector
as a template (Kurzchalia et al., 1992) and primers at the 5' end
generating a KpnI site either at the N-terminus of VIP21 (before
amino acid 1), or just before the hydrophobic sequence and the
C-tail (before amino acid 101), or before the C-tail only (before
amino acid 135); the same primer complementary to the vector
sequence was used for the 3' end in the three reactions. The three
PCR products were digested with KpnI and PstI, and cloned in
pGSAGH cut with the same enzymes. The resulting constructs
GSAGH-FL VIP, -HSC VIP, and -C VIP are fusion proteins consist-
ing of a glycosylation site linked to the segment of GH comprised
between residues 42 and 130, and either the full length VIP21, or the
hydrophobic sequence plus the C-tail (amino acids 102-178), or the
C tail of VIP (amino acids 135-178), respectively.
Two glycosylation sites were added to the wild-type VIP21, one at
the N-terminus of the protein and identical to the one just described,
the other added at the C-terminus, located at position 179, just after
the last codon of the native protein. This construct was made by
PCR, using VIP21 in pSP65 as a template, a 22 mer sense oligonu-
cleotide coding for amino acids 2-6 of the native VIP21 and having
a BamHI site at its 5' end, a 28 mer antisense primer coding for the
last 6 amino acids of VIP21 and for a glycosylation site including a
KpnI site. The PCR product was digested with BamHI and KpnI, and
cloned in the GSAGH-C VIP. The resulting clone GSVIPGS encodes
a modified VIP21 with three extra residues at the N-terminus (Asn
Gly Thr) located before amino acid 2 of the native VIP21, and with
Asn Gly Ser located after the last residue of the native VIP21 and
followed by the duplicate of the C-tail of the protein (43 amino
acids).
The truncated form of VIP21 (TR VIP) was obtained by cloning
the NcoI-KpnI fragment of VIP21 in a plasmid providing the new
initiation codon, pSP450 (Monier et al., 1988) and cut with NcoI and
KpnI. The resulting TR VIP clone encodes the VIP21-caveolin pro-
tein deleted of its first 31 amino acids.
The modifications introduced in the various plasmids were con-
firmed by DNA sequencing.
In Vitro Transcription, Translation, Translocation,
and Post-translational Assays
All of the cDNAs used for in vitro transcription were cloned in
vectors pSP64 or pSP65, under the control of the SP6 promotor. In
vitro transcription, translation in the wheat germ system, and trans-
location across dog pancreas microsomes were carried out as pre-
viously described (Monier et al., 1988). Puromycin-high potassium-
washed rough microsomes (PKRM), SRP, and reconstituted
proteoliposomes (Gorlich and Rapoport, 1993) were generous
gifts of Berit Jungnickel and Tom Rapoport (MDC, Berlin-Buch,
Germany).
The flotation assay was performed either under high salt or under
alkaline pH conditions as follows: 10 ,ul of translation mix was
adjusted to 0.6 M NaCl and 20 mM EDTA (high salt flotation) or to
0.24 M Na2CO3, pH 13, and 2 M sucrose (alkaline pH), and both
were incubated on ice for 30 min. A 2.1 M sucrose (final concentra-
tion) was added to the latter sample, mixed well, and 0.6 ml of both
samples were overlaid by 0.8 ml of 1.3 M sucrose and 0.8 ml of 0.5
M sucrose, all the sucrose solutions being adjusted to the same salt
concentration or to the same pH as the sample being processed.
After a 2.5-h centrifugation at 50,000 rpm in a SW60 rotor, the
floated membranes were recovered at the 0.5 M/1.3 M interface; the
fraction that remained in the 2 or 2.1 M sucrose represents the free
fraction, i.e., nonmembrane associated. Both fractions were precip-
itated with trichloroacetic acid and analyzed by SDS-PAGE.
The protease protection assay was performed by incubating on ice
the in vitro-translated samples in the presence of 0.7 mg/ml pro-
teinase K for 1 h or in the presence of a mixture of trypsin and
chymotrypsin at 0.14 mg/ml each for 80 min. PMSF (10 mM) or 1000
U/ml aprotinin was added to inactivate the proteinase K and the
trypsin/chymotrypsin, respectively, before solubilizing the reaction
mix in the usual SDS-PAGE sample buffer. The endoglycosidase F
treatment was carried out as follows: translation products were
denaturated by boiling in the presence of 0.5% SDS and 1% ,3-mer-
captoethanol; 1.25% NP40 was then added and samples were incu-
bated without (mock treatment) or with 5 U/ml endoglycosidase F
for 1 h 40 min at 37°C. The reaction was stopped by adding the gel
sample buffer and boiling.
The post-translational assay used for generating VIP21-caveolin
oligomers in vitro was performed according to the following pro-
cedure: after usual protein synthesis, 4 ,ul translation mix were
incubated for 90 min at 30°C in the presence of cytosol (a 100,000 x
g supernatant of HeLa or MDCK cells, homogenized using a ball-
bearing homogenizer in 50 mM N-2-hydroxyethylpiperazine-N'-2-
ethanesulfonic acid (HEPES), pH 7.2, 1 mM Mg(OAc)2, 90 mM
KOAc, 0.5 mM DTT, 1 mM ATP) in a total volume of 6-8 Al. In
some experiments, to keep the reaction volume small enough so that
it could be loaded on the gel without further treatment, the trans-
lation mix was centrifuged at 12,000 rpm for 4 min before the
post-translational assay, the supematant was discarded, and the
pellet was resuspended in a buffer (HMKD) containing the same ion
concentration as the translation mix: 20 mM HEPES, pH 7.6, 1 mM
Mg(OAc)2, 60 mM KOAc, 0.2 mM DTT; this centrifugation step had
no influence on the oligomerization process. The various cell ex-
tracts contained between 20 and 70 mg/ml protein, and were used
at a final concentration of 5-12 mg/ml. The role of some potential
components of the cytosol was tested by using various reagents
added to the cytosol just before its addition to the translation mix: 10
mM EDTA, EGTA, or GMP-PCP, or 10 mM deoxyglucose plus 20
,Lg/ml hexokinase were used for testing the role of Mg2+, Ca2+,
GTP-, and ATP-hydrolysis, respectively, on the oligomerization
process. The possible role of proteineaceous components of the
cytosol was investigated by using a cytosol treated with the mixture
trypsin/chymotrypsin at 0.14 mg/ml for 90 min on ice. The pro-
teases were inactivated by 1000 U/ml of the protease inhibitor
aprotinin, and this mixture was used in the post-translational assay
as usual. The reaction products were analyzed by SDS-PAGE with-
out boiling, unless otherwise indicated. Various processing was
performed on the post-translational reaction mixture. The CHAPS
extraction was performed according to Fiedler et al. (1993), except
that smaller volume was used to avoid precipitating the sample
with trichloroacetic acid; the trypsin/chymotrypsin digestion was
performed the same way as for the protease protection assay of
microsomes.
RESULTS
VIP21-Caveolin Is Extracted from Lung and
Cultured MDCK Cells in the Forn of High
Molecular Mass Complexes Consisting of VIP21-
Caveolin Monomers
Previous work has shown that, upon treatment of
TGN-derived vesicles or of purified membrane frac-
tion with the detergents CHAPS or Triton X-114 (Kurz-
chalia et al., 1992; Fiedler et al., 1993), VIP21-caveolin
was found in large, insoluble structures. The protein
was detected as a 21-kDa protein or a 21- to 20-kDa
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doublet, after SDS-PAGE and immunoblotting using
anti-N or an anti-C terminus antibodies, respectively
(Dupree et al., 1993). Our present work was aimed at
characterizing components present in the VIP21-
caveolin containing high molecular mass structures,
and likely to be interaction partners of the protein in
the cell.
A mild treatment of the CHAPS insoluble material
isolated from MDCK cells with SDS was performed.
The solubilization with SDS-PAGE sample buffer at
25°C resulted in the appearance of high molecular
mass complexes, separated on a 2.5-7.5% acrylamide
gel and detected by immunoblot using an antibody
directed against the N-terminus of VIP21-caveolin
(Figure 1, lanes 1 and 3). These complexes were not
oxidized forms of VIP21-caveolin because the sample
buffer contained 2% ,3-mercaptoethanol. Because esti-
mation of the exact molecular masses of these com-
plexes is difficult, we will refer to them as 200-, 400-,
and 600-kDa complexes. They were disrupted par-
tially upon boiling in the standard (pH 6.8) SDS-PAGE
sample buffer (Figure 1, lane 2), or totally after boiling
in alkaline sample buffer (Figure 1, lane 4). This gel did
not allow the detection of the 21-kDa VIP21-caveolin
monomer because proteins below 60 kDa migrated
with the dye front.
The further analysis of the VIP21-caveolin-contain-
ing complexes was performed using TIFF from dog
lung as a starting material (Fiedler et al., 1993). Indeed,
lung is one of the tissues in which VIP21-caveolin,
Boiling
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-+- +
-
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1 2 3 4
-584K
-389K
-292K
-205K
-1 16K
-97K
-68K
Figure 1. VIP21-caveolin is found in the form of high molecular
mass complexes in MDCK cells. CHAPS-insoluble material from
MDCK-cells was solubilized either in the standard SDS-PAGE sam-
ple buffer (lanes 1 and 2) or in the alkaline sample buffer (lanes 3 and
4) and incubated either at 25°C (lanes 1 and 3) or boiled for 5 min
(lanes 2 and 4). The samples were analyzed on a 2.5-7.5% gel, which
was blotted and subsequently incubated with VIP21-N antibodies.
Arrows indicate high molecular mass complexes. Molecular mass
markers here and in subsequent figures are: cross-linked hexamer of
rabbit muscle phosphorylase b (584 K), tetramer of rabbit muscle
phosphorylase b (389 K), trimer of rabbit muscle phosphorylase b
(292 K), rabbit muscle myosin (205 K), ,B-galactosidase (116 K),
rabbit muscle phosphorylase b (97 K), bovine serum albumin (68 K),
chicken ovalbumin (45), bovine pancreas trypsinogen (24 K), and
soybean trypsin inhibitor (20 K).
detected by immunoblot, is quite abundant (Glenney,
1992). A similar high molecular mass complex pattern
was detected in CHAPS-pellet from MDCK cells and
in TIFF from the lung. This pattern was also seen in a
total membrane fraction not treated with detergent
(our unpublished observation).
To purify the VIP21-caveolin-containing com-
plexes from lung and characterize its composition,
we used the fraction P from TIFF (see MATERIALS
AND METHODS). The sample was solubilized in
SDS at 25°C and submitted to a velocity sucrose
gradient centrifugation. Fractions were collected,
analyzed by SDS-PAGE after treatment at 25°C or at
95°C, and the VIP21-caveolin-containing complexes
were detected by immunoblot using the VIP21-N
antibody. The major species detected was the 400-
kDa complex plus a minor 600-kDa band found in
fractions 1 to 3 from the bottom of the tube (Figure
2A, lanes 1-3, arrow). After boiling (Figure 2B), the
complexes were disrupted and generated the VIP21-
caveolin of 21 kDa (Figure 2B, lanes 1-3, arrow-
heads). When the same SDS-solubilized starting ma-
terial was boiled before centrifugation, VIP21-
caveolin remained at the top of the gradient as a
21-kDa species (our unpublished observation). The
silver staining of the same gels is shown in Figure 2,
C and D, and clearly indicates that boiling of the
400-kDa species, essentially present in lanes 1-3
(Figure 2C, arrow), led to the appearance of the two
20- to 21-kDa VIP21-caveolin isoforms (Figure 2D,
lanes 1-3, arrowheads). The complex was further
purified by a second velocity gradient centrifuga-
tion. Within the detection limits of silver staining, it
resolved exclusively into the VIP21-caveolin upon
boiling (Figure 2E). The 400-kDa complex was sub-
jected to analytical centrifugation for determination
of its sedimentation properties. The obtained S20,W
value of 14.4 together with the shape and size of the
particle will allow more accurate estimation of the
molecular mass of the complex (see below).
Electron Microscopy of TIFF and of Purified
400-kDa Complex
Examined morphologically, TIFF comprised heteroge-
neous membranous material. Large sheets of mem-
brane, smaller vesicle-like structures, plus lamellae-
like material were all observed (Figure 3A). This
material was not labeled by VIP21-N antibodies but
labeling was seen in patches on the membranous
structures (our unpublished observation).
Different fractions of the SDS-treated lung TIFF
separated by density gradient centrifugation were
examined by negative staining. Fractions 1 and 2,
which correspond to 400-kDa complexes (see Figure
2C), consisted of small groups of mainly ovoid
structures (Figure 3, B-E). The majority of these
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Figure 2. The high molecular mass com-
-205K plexes contain only VIP21-caveolin mono-
mers. The P fraction from TIFF (see MA-
TERIALS AND METHODS) was treated at
25°C before centrifugation on 10-30% su-
crose gradients. Fractionation was per-
formed from the bottom of the gradient
and the numbers of the lanes correspond to
the numbers of the gradient fraction. Ali-
quots of the fractions after centrifugation
were treated at 25°C (panels A and C) or
boiled (panels B and D). SDS-PAGE on a
2.5-15% gel, and either blotting to nitrocel-
-24K lulose and staining with VIP21-N antibod-ies (panels A and B), or silver staining
-20K (panels C and D) were performed. Panel E
shows the silver staining of the purified
400-kDa complex treated at 25'C (N) or
boiled (B). Arrow indicates high molecular
mass complexes; arrowheads indicate
VIP21-caveolin monomers.
structures were 15-17 nm long and 8-10 nm wide
although larger particles were also occasionally ob-
served. Most of these particles were present in
groups. These structures were labeled by affinity-
purified VIP21-N antibodies (Figure 3E). Fraction 5
contained large groups of ovoid structures as well
as some thin filamentous material whereas fraction
8 contained lamellae-like material (similar to the
VIP21-caveolin negative structures seen in the
TIFF), which we assume represents lipid-rich com-
plexes.
The estimation of the molecular mass of the 400-kDa
complex was based on the dimensions and the shape
of the particle and also on the amino acid composition
of VIP21-caveolin. Taking into account different
amounts of bound SDS, different molecular masses of
the protein fraction in the complex were obtained
(from 253 to 548 kDa for 50 and 100% of protein in the
complex, respectively). This data together with the
S20,W value were used to calculate the diffusion coef-
ficient as well as the frictional ratio (f/fo). The esti-
mated value of the frictional ratio for the microscopi-
cally observed particle can be compared with values
calculated for different SDS-protein complexes on the
basis of hydrodynamic experiments. The best fit was
observed at about 40% of bound SDS. We can specu-
late that the protein portion of the particle was about
310 kDa and would correspond to about 15 molecules
of VIP21-caveolin in the 400-kDa complex. The differ-
ence observed in molecular mass determined by SDS-
PAGE can be explained by the fact that samples were
not heat denatured. Also, the presence of lipids in the
complex can further impair the molecular mass deter-
mination.
VIP21-Caveolin Is Found in High Molecular Mass
Complexes Shortly After It Is Synthesized
As shown above, VIP21-caveolin was isolated at
steady state in the form of high molecular mass
complexes. Similar complexes were immunoprecipi-
tated from a total MDCK cell extract, after an over-
night metabolic labeling and subsequent immuno-
precipitation with the VIP21-N antibody (Figure
4A). The cells were solubilized with a buffer con-
taining 1% NP40, 0.4% sodium deoxycholate, and
0.4% SDS before immunoprecipitation. Upon boil-
ing in the standard sample buffer, the high molec-
ular mass complexes dissociated partially, generat-
ing exclusively the VIP21-caveolin monomers
(Figure 4A, compare lanes 1 and 2) in about equimo-
lar proportion. Some weak bands of approximately
45, 54, 100, and 220 kDa represented nonspecific
background noise, which could not be competed
with a large excess of N-peptide included in the
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Figure 3. Morphological analysis of lung TIFF and purified 400-kDa complex. (A) TIFF was applied to a grid and immunolabeled using
affinity-purified VIP-N antibodies before negative staining. Heterogeneous membranous structures, some of which are several microns in
size, are apparent. Arrays of striated lamellae-like material, often arranged in concentric rings (see arrowheads), are abundant. Groups of
VIP2-N gold particles are associated with various membrane fragments (e.g. see arrows) but rarely with the striated material. (B-E) TIFF was
treated with SDS and was separated by sucrose density gradient centrifugation (see Figure 2). Fractions 1 and 2 were applied to grids and
negatively stained. In panel E, the complexes were treated with antibodies to VIP21-caveolin before negative staining. The VIP21-caveolin
complexes consist of ovoid structures usually clustered in groups which are labeled strongly with VIP21-N antibody (E). Note that in panel
E, the structure of the individual ovoid structures is masked by the layer of antibody-protein A complexes. Bars: A, 500 nm; B-E, 50 nm.
immunoprecipitation assay (Figure 4A, compare
lanes 3 and 4 to lanes 1 and 2).
A time-course study of the VIP21-caveolin com-
plex appearance was performed on HeLa cells per-
manently transfected with VIP21-caveolin cDNA,
placed under the control of an inducible promotor,
and thereby expressing a larger amount of VIP21-
caveolin than the parent cell line or than the
nontransfected MDCK cells. The majority of the
VIP21-caveolin transfectants analyzed expressed
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A B C Figure 4. VIP21-caveolin isfound in high molecular mass
BFA + complexes early after its syn-
thesis is completed; the com-
-N --+hse0420as44plex formation is insensitiveocN ocN + Chase 0 4 10 20 Chase 1 4 1 4 to brefeldin A treatment. (A)
N-pept. (min) (h) , , MDCK cells were metabolicallylabeled overnight with [35S]me-
N B N B NB N B N B NB NBNBNBNB thionine, the cells solubilized
and immunoprecipitated with
the VIP-N antibody, and the im-
munoprecipitate was solubi-
lized in the standar&SDS-PAGE
sample buffer and treated at
L205K 1 .1! * t | | * ''t * 25'C (N, odd number lanes) orboiled (B, even number lanes)2 205K before analysis by SDS-PAGE
-97K ! on a 2.5-16% acrylamide gradi-
8K ent gel and autoradiography. 25
-45K -97K 97K- ,g/ml N-peptide was added248K 8K together with the VIP-N anti-
24K K body as indicated (lanes 3 and
0 4). (B) HeLa cells permanently
.......45K ~~~~transfected with VIP21-caveolin1 2 3 4 45K
cDNA were pulsed-labeled for 7
min and chased for up to 20
-24K w -24K min. Cells solubilized at differ-.,. ---2{}K M20K ent times of chase were immu-
noprecipitated and treated as
1 2 3 4 5 6 7 8 1 2 3 4 5 6 7 8 described in panel A, exceptthat the immunoprecipitates
were solubilized in the alkaline
SDS-PAGE sample buffer. (C) VIP21-caveolin-transfected HeLa cells were incubated in methionine-free medium for 30 min, pulse-labeled for
10 min, and chased for 1 h or 4 h; 5 jig/ml brefeldin A (BFA) was present during all these incubations. Immunoprecipitates were treated as
indicated in panel B.
predominantly the larger isoform of the protein,
and, as a possible consequence, the complexes im-
munoprecipitated by the VIP21-N antibody are of
slightly different sizes (approximately 150, 300, and
400 kDa) than the ones identified in MDCK cells
(Figure 4, panels B and C compared with panel A).
After a 7-min pulse with radioactive methionine and
no chase, a faint but definite band corresponding to
the 300-kDa molecular mass complex could already
be detected (Figure 4B, lane 1). The amount of com-
plexes formed was more visible after a short chase
period of 4 min or more (Figure 4B, from lane 3 on)
and they resolved into the VIP21-caveolin monomer
upon boiling in alkaline buffer.
Furthermore, brefeldin A, a drug that induces the
redistribution of the Golgi to the ER (preventing the
normal transport of proteins beyond the Golgi ap-
paratus), did not seem to affect the formation of
VIP21-caveolin oligomers, even if it was added 30
min before the 10-min pulse and was present during
up to 4 h of chase (Figure 4C, lanes 1 and 3, com-
pared with lanes 5 and 8). The results of these
pulse-chase experiments strongly suggest that the
complexes were formed early after the synthesis of
the protein was completed and that no post-Golgi
step is needed.
The Hydrophobic Segment of VIP21-Caveolin
Is a Signal/Anchor, Mediating the Cotranslational
Insertion of the Protein into the Microsomal
Membranes through the Classical
Translocation Machinery
Although VIP21-caveolin was shown to be localized
to the TGN, to the TGN-derived vesicles, and to the
caveolae, the actual site of integration of VIP21-
caveolin into the membranes is not known. In addi-
tion, data concerning the orientation of the pro-
tein within the membrane are controversial (Dupree
et al., 1993; Lisanti et al., 1993; Sargiacomo et al.,
1993).
The amino acid sequence of VIP21-caveolin pre-
dicts no cleavable aminoterminal signal peptide but
shows a single hydrophobic sequence of 33 amino
acids located 101 residues after the initial methio-
nine and followed by a 43-residue carboxy tail. We
examined whether this hydrophobic stretch could
serve as a signal sequence and mediate the insertion
VIP21-caveolin into the ER membrane using the
usual membrane/secretory protein pathway. We
used an in vitro transcription-translation-transloca-
tion system, which allowed us to study whether the
insertion of VIP21-caveolin into the membrane was
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Figure 5. VIP21-caveolin A B C
becomes inserted in the
membrane cotranslationally, DPM PKRM DP + TRAM
via the classical ER trans- post SRP -+location machinery. The in CO SEC 61 - +
vitro-produced VIP21-cave- --Hl -
olin RNA was used to pro- T M F T M F T M F T M F T M F M F M F
gram synthesis in the wheat
germ extract: (A) in the ab-
sence of dog pancreas micro-
somes (DPM, lanes 1-3,
"[minus]"), in the presence 29K
of DPM added at the begin- --i.-24K O_
ning of the translation (lanes .
_
20K
4-6, "co"), or added after OK
the translation was com- .
pleted (lanes 7 to 9, "post"); 14K 14K
(B) in the presence of PKRM 14K
added at the beginning of 1 2 3 4 5 6 1 2 3 4
the translation, alone (lanes
1-3), or together with SRP
(lanes 4-6); (C) in the pres- 1 2 3 4 5 6 7 8 9
ence of reconstituted vesicles
containing docking protein (DP) and TRAM (lanes 1 and 2) or containing these two proteins plus Sec6l (lanes 3 and 4). Two-thirds of the
translation mixture was submitted to flotation in the presence of high salt (A) or in alkaline pH (B and C) to separate the membrane fraction
(M) containing the integral membrane proteins from the fraction containing the noninserted, free protein (F). The rest of the total mixture (T)
before fractionation is also shown in panels A and B. Arrow designates VIP21-caveolin.
cotranslational, SRP dependent, and needed dock-
ing protein (SRP receptor) and Sec6l.
Dog pancreas microsomes were added at the begin-
ning of translation or after the synthesis was com-
pleted. Insertion of VIP21-caveolin into the membrane
was estimated by flotation of the translation product
in the presence of high salt or of alkaline pH. As
shown in Figure 5A, a substantial amount of VIP21-
caveolin was found in the membrane fraction (Figure
5A, lane 5) only when membranes were added co-
translationally (Figure 5A, lanes 4-6). In the absence
of membrane (Figure 5A, lanes 1-3) or when the
membranes were present post-translationally (Fig-
ure 5A, lanes 7-9), a very small amount of VIP21-
caveolin was associated with the membrane (Figure
5A, lanes 2 and 8).
The insertion of VIP21-caveolin was dependent on
the presence of SRP in the assay (Figure 5B). The
puromycin, potassium washed membranes (PKRM),
depleted of SRP, poorly supported the association of
VIP21-caveolin with the membranes (lane 2), whereas
the addition of exogenous SRP to the same membrane
preparation led to a high increase of the VIP21-caveo-
lin found in the membrane fraction (Figure 5B, lane 5
compared with lane 2).
Furthermore, proteoliposomes reconstituted with
purified Sec6l, docking protein, and TRAM (Gorlich
and Rapoport, 1993), identified as necessary and suf-
ficient components of the translocation apparatus,
were competent for VIP21-caveolin insertion (Figure
5C, lane 3). By contrast, reconstituted proteoliposomes
in which Sec6l was omitted were poorly efficient for
the VIP21-caveolin insertion (Figure 5C, lane 1).
Taken together, these results show that VIP21-
caveolin becomes inserted while it is synthesized by
the ER-bound ribosomes, that its insertion is per-
formed by the "classical" membrane/secretory pro-
tein translocation machinery, and that consequently
the hydrophobic domain serves as a signal/anchor.
Topology of VIP21-Caveolin
The disposition of VIP21-caveolin within the mem-
branes was studied on the in vitro-inserted VIP21 by
a protease protection assay. Both proteinase K and a
mixture of trypsin/chymotrypsin were used. As
shown in Figure 6A, the free VIP21-caveolin synthe-
sized in the absence of membrane and the mem-
brane-inserted protein showed a similar digestion
pattern when proteases were added to the transla-
tion mixture after the synthesis (Figure 6A, compare
lanes 2 and 5 and lanes 3 and 6, respectively). This
indicates that the insertion of VIP21-caveolin in the
membrane did not alter the sensitivity of the protein
to protease activity. Because the N-terminal, hydro-
phobic, and C-terminal segments all contain methi-
onine residues, any translocated and thus protected
fragment would have been visible, as is the mature
form of a secretory protein (GH) precursor synthe-
sized and processed in the same conditions (Monier
et al., 1988). This topology was confirmed by testing
a modified VIP21, GSVIPGS, in which two glycosy-
lation sites were added, one at the N-terminus at
position 2, the other at the C-terminus at position
179, just before the stop codon. As shown in Figure
6B, this new form of VIP21 did not become glyco-
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WT VIP GSVIPGS GSAGH-HSC VIP Figure 6. Both regions flanking VIP21-
caveolin hydrophobic segment are located
---1 r on the cytoplasmic surface of the ER; theDPM --- + + + - -- + + + + + - - - ++++ DPM replacement of the N-domain of VIP21-
T+C - + - - + - - +-+ + + + - T+C caveolin leads to a misorientation of thehydrophobic domain within the mem-PK - + - _ +
_
+
__ + - + - + + PK brane. (A) After synthesis in the absence
- - - - + - - Endo F (lanes 1-3) or in the presence of DPM
ww, --- _ . (lanes 4-6), a portion of the translation
mixture containing the wild-type VIP21-
8K68K caveolin (WT VIP) was mock-treated(lanes 1 and 4), or treated with a mixture
5K -45K of trypsin/chymotrypsin at 0.14 mg/ml
each for 80 min on ice (T+C, lanes 2 and
-36K -36K 5), or treated with 0.7 mg/ml proteinase K
for 1 h on ice (PK, lanes 3 and 6). (B)
2K -29K VIP21-caveolin bearing two glycosylation
s24ites (GSVIPGS, lanes 1-7) and a fusion=24K : l l "s. wprotein, GSAGH-HSC VIP (lanes 10-16),LI
20K were synthesized in the absence or in the
-320K iti 2, =i _ presence of DPM. GSAGH-HSC VIP con-
tains only the hydrophobic domain and
the C tail of VIP21-caveolin (amino acids
14K 102-178) added downstream from a
~~~~~~~~~~GSAGH segment consisting of a glycosy-
lation site (GS) followed by the amino ac-
ids 42-130 of rat pregrowth hormone
1 2 3 4 5 6 1 2 3 4 5 6 7 8 9101112 131415 16 (AGH). They were treated post-transla-
tionally either with trypsin/chymotrypsin
(lanes 2, 6, 11, and 15) or with proteinase K (lanes 3, 7, 12, and 16) as described in panel A, or with endoglycosidase F (Endo F, lanes 5 and
14). The closed arrowhead points to the glycosylated form of the fusion protein, the open arrowheads to its protected fragments, the
arrow to the background band also present when DPM alone was used and treated with the proteases (lanes 8 and 9).
sylated upon addition of DPM (Figure 6B, compare
lanes 1 and 4-5). Again, no protected fragment dif-
ferent from the ones observed in the absence of
membrane was detected (Figure 6B, lanes 2-3 and
6-7). The bands marked with an arrow are nonspe-
cific for this construct and are present also when
membranes alone, without RNA, were treated in the
same conditions (Figure 6B, see lanes 8 and 9).
These results indicate that neither the N- nor the
C-terminus of the native VIP21 or of GSVIPGS
reached the microsomal lumen. The disposition of
VIP21-caveolin within the membrane was therefore
in a loop configuration, exposing the bulk of the
protein to the cytoplasmic surface of the micro-
somes.
The formation of the unusual hairpin structure
hereby detected was then shown to be dependent
on the presence of the amino terminal domain of
VIP21-caveolin. The N-portion flanking the hy-
drophobic region was deleted and replaced by a
sequence derived from GH deleted of its signal
peptide and including a glycosylation site (see MA-
TERIAL AND METHODS); the hydrophobic do-
main and the carboxy tail remained unmodified. In
contrast to the results just described, a fraction of
GSAGH-HSC VIP became glycosylated upon addi-
tion of microsomal membranes (Figure 6B, closed
arrowhead, lane 10 compared with lane 13). The
glycosylated protein was sensitive to the endogly-
cosidase F treatment (Figure 6B, lane 14). Upon
treatment with trypsin/chymotrypsin, the fusion
protein generated a protected fragment, which
comigrated with the glycosylated form of the pro-
tein (Figure 6B, lane 15); the other fragments were
not specific for the membrane-associated form (Fig-
ure 6B, compare lanes 11 and 15). The digestion with
proteinase K, which has a broader spectrum than
trypsin and chymotrypsin, yielded also to the pro-
duction of protected peptides specific for the mem-
brane-processed form (Figure 6B, open arrowheads,
compare lane 16 with lane 12). This indicates that
the N-region of this fusion protein was translocated
into the lumen of the vesicles. When the same seg-
ment GSAGH was added upstream to the full length
VIP21-caveolin, the new protein GSAGH-FL VIP did
not become glycosylated although it was membrane
associated (our unpublished result). This result in-
dicates that the topology of this protein was the
same as the one of the wild-type VIP21-caveolin and
of GSVIPGS. A fusion protein made of GSAGH
linked to the C-tail of VIP21-caveolin was used as a
control and was not membrane inserted and not
glycosylated (our unpublished result). This last re-
sult confirmed that the hydrophobic segment of
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VIP21-caveolin indeed had the function of a signal
peptide.
Taken together, these observations show that the
presence of the sequence including the hydrophobic
stretch plus the C-tail, from residues 102-178, was not
sufficient to induce the loop configuration and to pre-
vent the region preceding it to cross the membrane
bilayer. This suggests that the stable hairpin structure
observed in the native VIP21-caveolin may result from
interactions between the regions flanking the signal/
anchor.
VIP21-Caveolin Forms Oligomers In Vitro
Because the VIP21-caveolin oligomerization process
was shown to be an early post-translational event,
possibly taking place in the ER or in a close post-ER
compartment, we studied whether oligomerization of
in vitro-synthesized VIP21-caveolin could occur. Our
previous results showing that oligomers consisted of
both isoforms of VIP21-caveolin led us to test them
both. It was proposed, according to a mass spectrom-
etry study (Dupree, Kellner, and Kurzchalia, unpub-
lished data), that the smaller isoform of VIP21-caveo-
lin would derive from the longer one by the use of an
alternative initiation codon located 32 residues after
the first one. The smaller isoform, then named trun-
cated VIP (TR VIP) was therefore generated for the in
vitro purposes by deleting the nucleotides encoding
the first 31 amino acids of the full length clone, or
wild-type VIP (WT VIP). In vitro-synthesized TR VIP
indeed comigrated with the small isoform of VIP21-
caveolin immunoprecipitated from metabolically la-
beled MDCK cells. Figure 7 shows that VIP21-caveolin
could also, in vitro, be found in high molecular mass
complexes. Both TR VIP and WT VIP were able to
generate oligomers (Figure 7, panels A and C, respec-
tively), although TR VIP was much more efficient:
about 12% of the protein was found in the form of
oligomers. TR VIP produced two major species of
complexes of about 200 and 400 kDa, of similar sizes
as those detected in vivo, and several minor bands of
approximately 190, 320, and 600 kDa. They resolved
into monomers upon boiling in alkaline SDS-PAGE
sample buffer (Figure 7, panel B, compare lanes 6 and
7). The complexes containing the WT VIP were of
slightly different size (Figure 7C), about 300 and 600
kDa. The complexes formed, in both cases, only when
VIP21-caveolin was inserted into the ER membranes
(Figure 7, A and C, compare lanes 1 and 2) and when
cytosol was added to the assay (Figure 7B, compare
lanes 1 and 6). The amount of complexes formed in
vitro increased as a function of the amount of cytosol
added in the post-translational assay (Figure 7B, com-
pare lanes 2-6 to lane 1) and as a function of incuba-
tion time: after 5 min the oligomers could be detected,
after 1 h, the maximal was reached (our unpublished
result).
That the VIP21-caveolin insertion into the mem-
brane was a prerequisite for a cytosol-dependent oli-
gomerization was demonstrated by the fact that no TR
VIP oligomer was formed 1) when membrane non-
competent for translocation (depleted of SRP) was
used, or 2) when membrane was added post-transla-
tionally. Furthermore, the amount of complexes
formed during the post-translational assay increased
as a function of membrane-inserted TR VIP present in
the assay. In contrast, free nonlabeled in vitro-pro-
duced TR VIP, synthesized in the absence of mem-
brane, added in increasing amount to a fixed quantity
of labeled membrane-inserted VIP, did not alter the
amount of formed complexes. This rules out the pos-
sibility of a nonspecific aggregation of VIP21-caveolin
due to some structural feature like, for example, the
presence of a long hydrophobic domain sticking to the
membrane, a process facilitated or promoted by cy-
tosol. Moreover, the oligomerization studied in vitro
was clearly not induced by treatment of the post-
translational mixture by the detergent SDS. Indeed,
when the post-translational assay was performed at
4°C and then the detergent added to the sample for
SDS-PAGE processing, no oligomer was detected (Fig-
ure 7A, lane 8). The oligomer formation was blocked
by addition of 10 mM GMP-PCP to the cytosol (Figure
7D, lane 2 compared with lane 1), as well as by deple-
tion of the ATP content of cytosol by addition of
hexokinase-deoxyglucose (Figure 7D, lane 8 compared
with lane 6). Addition of EDTA, but not of EGTA,
abolished VIP21-caveolin oligomerization (Figure 7D,
lanes 3 and 4, respectively). Such dependence of oli-
gomer formation on GTP- and ATP-hydrolysis, and
on the presence of Mg2' but not of Ca + again rules
out the possibility that the oligomers we could gener-
ate from in vitro-synthesized VIP were merely the
result of SDS action on the protein. The complexes
formed in vitro were not CHAPS insoluble and were
found in the supernatant phase after the detergent
extraction (Figure 7B, lanes 9 and 10), whereas their
counterparts purified from tissue or cells were insol-
uble (see Kurzchalia et al., 1992).
Finally, the sensitivity of the complexes to the tryp-
sin/chymotrypsin (T+C) treatment was studied. The
complexes were incubated with the proteases just after
the post-translational assay, before any detergent ad-
dition, and generated degradation products visible as
smears (Figure 7E, lane 9) of about 68, 200, and 300
kDa. Only the 200- and the 68-kDa smears were de-
tected when proteinase K, which has a broader spec-
trum, was used instead of T+C (our unpublished
observation). When the post-translational mix was
first complemented with 0.5% Triton X-100, the profile
of the complexes obtained was slightly modified (Fig-
ure 7E, compare lanes 8 and 10): the complexes higher
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A B C Figure 7. VIP21-caveolin, in-
serted into the microsomal
DPM - + + + + ++++ + + - + membranes in vitro, oligomer-
Cytosol + + (p1) 0 0.10.20.5 1 2 2 2 2 + + izes in a cytosol-dependent
B 4oCT. manner. (A and C) After a 90-
min translation in the absence
(lane 1) or in the presence of
DPM (lane 2), 5 ,ul of TR VIP
110sl!K:b:ilr..,
N (A) or of WT VIP (C) was in-
cubated at 30°C for 1 h in the
presence of MDCK cytosol.
-.t -2(}5K siis .,,t. -205K 205K Samples were then solubilized
in the alkaline SDS-PAGE
sample buffer and loaded on
97K 7K 7 the 3-16% acrylamide gradi-
ent gel without boiling. (B) Af-
K K ter synthesis of TR VIP in the
45K presence of DPM, 4 ILI aliquots45K 45K of translation mixture were
centrifuged and resuspended
_M&P-t-lkz;u::nt54;t -24Kin 4 .lI of HMKD buffer, sup-24K24K 24K plemented with variouslEI)Ke !20K 20K Kamounts of MDCK cell cytosol
as indicated at the top of the1 2 1 2 3 4 5 6 7 8 9 10 1 2 figure (lanes 2-10) or buffer
alone (lane 1) and incubated
D E for 60 min at 30°C for all sam-
s M X M ples except the one in lane 8,
GMPPCSP -+ r-- .--w ; + + + ++ + + ++ + + DPM which was incubated at 4°C.
EJDT'A- - + + +++ + + + + ++ + Cytosol After the post-translational in-Ni det.' 'X 140 CHAI'S cubation, samples wereEGTA - - - + ,- Z.r-1-treated as described in A and
H1K+DI)()(. - ++ - + + -+ C+Cc, except for the sample in
,,,,,,,__oc_ _ _lane 7, which was boiled, and
one sample that was treated
4rn" _ sg- F l! with CHAPS and centrifuged;
the supernatant (S, lane 9) and
S"Mx,2{g k; the pellet (P, lane 10) were
in"-||0{>SK 205K treated as described for A and
C. (D) TR VIP translated in the
presence of DPM was incu-
97K 97K bated in the presence of cy-
tosol alone (lane 1), in the
8K l8K presence of cytosol supple-
mented with 10 mM GMP-
-45K PCP (lane 2), 10 mM EDTA(lane 3), or 10 mM EGTA
(lane 4) for 1 h at 30°C. In
2_^I-24K; _ _ l _-2{ > lanes 5-8, identical aliquots of
-20K 20 the translation were used, but
l 2 3 4 5 6 7 X 1 2 3 4 6 7 8 910 11 1213 were centrifuged before the
- 4678 post-translational assay and
separated into the membrane
pellet (M, lanes 6 and 9) and supernatant (S, lanes 5 and 7). Cytosol alone (lanes 5 and 6) or cytosol plus deoxyglucose (DOG) and hexokinase
(HK) (lanes 7 and 8) was added and incubated as described above. Samples were processed as in A and C. (E) TR VIP was synthesized in
the presence or in the absence of DPM and, in the post-translational assay, in the presence or in the absence of cytosol, as indicated on the
figure. The digestion with trypsin/chymotrypsin (T+C) for 80 min on ice followed by the inactivation of the enzymes by a protease inhibitor
was performed either on the translation products before addition of cytosol (lanes 2 and 4), or on the cytosol before its addition to the
translation mix (lane 6), or on the samples after incubation with cytosol (lanes 9, 11, and 13). The samples described in lanes 8 to 13 were either
not treated with detergent (no det, lanes 8 and 9), complemented with 0.5% Triton X-100 (TX100, lanes 10 and 11), or extracted with 20 mM
CHAPS (lanes 12 and 13) before the protease treatment; in the former case, the supernatant fraction contained the oligomers (see Figure 7B,
lane 9) and is shown in lanes 12 and 13. The sample in lane 7 was incubated in the presence of cytosol plus the protease inhibitor alone.
Samples were processed as in panels A and C.
than 400 kDa disappeared while a minor species (the treated complexes (Figure 7E, lane 11) or to the com-
product of approximately 300 kDa) became more plexes found in the supernatant fraction after CHAPS
prominant. The addition of T+C to the Triton X-100- extraction (Figure 7E, lane 13), yielded to the appear-
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ance of degradation products of similar size to the
ones obtained in the absence of detergent (Figure 7E,
lane 9), except for the 300-kDa product, which was not
present when the CHAPS fraction was digested. These
data indicate that the presence of Triton X-100 and
CHAPS, and consequently the modification of the
lipid environment of the oligomers, did not alter the
overall structure of the complexes because no addi-
tional recognition sites for the proteases was revealed,
as compared with the samples not treated with deter-
gent. However, there were minor changes in the prop-
erties of the complexes: the very large forms of the
complexes (more than 600 kDa) seemed to be better
solubilized by Triton X-100, and CHAPS made TR VIP
in the 300-kDa complex more accessible to proteases.
As controls, the VIP-containing microsomes and the
cytosol were independently treated with proteases be-
fore their use in the post-translational assay. This
treatment led to the partial degradation of TR VIP
(Figure 7E, lanes 2 and 4) and abolished its capacity to
oligomerize in the presence of cytosol (Figure 7E, lane
4 compared with lane 3). Similarly, a T+C-treated
cytosol failed to induce the oligomerization of TR VIP
(Figure 7E, lane 6). It must be noted that the protease
inhibitor used for inactivating the enzymes had no
influence on the complex formation (Figure 7E, lane 7)
and totally inhibited the protease activity as observed
in Figure 7E, lane 6, where the amount of the mono-
meric form of TR VIP was the same as when no
protease was used (Figure 7E, compare lane 6 with
lane 5).
The Oligomerization of the In Vitro
Membrane-inserted VIP21-Caveolin Does Not
Involve a Vesicle Fusion Step
The formation of high molecular mass complex from
monomers implies the accumulation of the protein
within membrane microdomain, which would make it
possible for the protein monomers to oligomerize un-
der the control of a cytosolic factor(s); indeed, at least
15 molecules of VIP21-caveolin should theoretically be
present in a single vesicle to form a 400-kDa complex.
This could be the result of a VIP21-caveolin clustering
in a particular region of the membrane, or, alterna-
tively, this could be achieved by the fusion of several
vesicles, each one possibly having a low content of
inserted VIP21-caveolin.
We tested whether the oligomer formation involved
a step of vesicle fusion by generating three different
populations of microsomes in vitro: one containing the
membrane-inserted WT VIP, one the TR VIP, and one
in which both the WT and the TR VIP were cotrans-
lationally inserted. The post-translational assay was
then performed on the three types of vesicles and in a
fourth test tube in which an equivalent amount of
membrane-inserted TR and WT VIP was added. The
reaction products were analyzed on 2D gel, as de-
scribed in MATERIAL AND METHODS: the first di-
mension allows the separation of the complexes under
nonboiling condition, the second dimension allows
the analysis of the complex content after boiling. As
already seen in Figure 7C, WT VIP generated two
types of complex, which were disrupted upon boiling
in alkaline conditions, and generated the monomers
indicated by the arrows in Figure 8A. Similarly, TR
VIP (Figure 8B) was found in two species of oligomers,
which were also disrupted by boiling; the migration of
the monomeric forms (indicated by arrowheads) more
to the left as compared with WT VIP, indicates that the
size of the TR VIP oligomers was slightly smaller.
Figure 8C shows the comigration of both WT VIP and
TR VIP monomers, indicating that both isoforms were
present in the same complexes. This was achieved
when both proteins were co-synthesized in the pres-
ence of DPM. In contrast, no mixed complex was
observed (Figure 8D) when the two proteins were
added together in the post-translational assay after
completion of their synthesis and of their membrane
insertion. This result argues against a vesicle fusion
step involved in the formation of VIP21-caveolin
oligomer during the post-translational incubation.
In addition, the data shown in Figure 8C indicate
that the complexes containing both WT and TR VIP
were the size of the TR VIP-generated complexes,
and not the size of the WT VIP-generated com-
plexes. This latter observation together with the
higher efficiency of TR VIP to form complexes may
be indicative that TR VIP is the initiator, and may be
a nucleation factor, for the oligomer formation.
DISCUSSION
Our present work shows that VIP21-caveolin, found in
the TGN and on the inner surface of the plasma mem-
brane as a part of the coat covering the caveolae, is
able to form oligomers. The high molecular weight
structures seem to be composed for the major part of
VIP21-caveolin and membranes; indeed, the complex
insolubility in detergents such as CHAPS and Triton,
and its flotation ability are taken as lines of evidence
for a structure rich in glycolipids (glycosphingolipids).
The VIP21-caveolin-containing complexes could be
resolved into essentially either or both VIP21-caveolin
isoforms, excluding any other products. This was
shown for the biochemically isolated 400-kDa complex
as well as for newly synthesized VIP21-caveolin poly-
mers in vivo and for the complexes formed in vitro.
Previous reports showing that VIP21-caveolin can be
co-isolated with various other cell components shar-
ing the same biological properties, for example the
Triton X-100 insolubility of VIP21-caveolin, GPI-an-
chored proteins, glycosphingolipids, and others (Fied-
ler et al., 1993; Lisanti et al., 1994), have correlated this
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with a physiologically relevant protein-protein inter-
action. However, our results strongly suggest that
VIP21-caveolin has the primary capacity of oligomer-
izing and that the high molecular mass complexes
represent the forms under which VIP21-caveolin is
found in the detergent-insoluble fraction. Whether
these structures, visualized as ovoid after a mild SDS
treatment, may represent the basic unit of the striated
coat covering the inner surface of caveolae (Rothberg
et al., 1992), and whether VIP21-caveolin already as-
sembled in oligomers in the ER is still compatible with
its possible role in the sorting of caveolae-destined
proteins (Sargiacomo et al., 1993), remain to be clari-
fied.
Unlike other coat proteins identified so far, VIP21-
caveolin is an integral membrane protein, and, as
shown in this paper, it becomes integrated into the
membrane in the ER, where it is synthesized. Its
unique hydrophobic domain, which then must serve
as a signal peptide and as a signal anchor, is located
101 amino acids after the initial methionine and is
followed by a short C tail (43 residues), and must
emerge from the synthesizing ribosomes nearly at the
same time as the peptide chain terminates. However
the integration of the protein within the membrane is
clearly cotranslational and involves the now well de-
fined components for ER translocation, SRP and the
docking protein on the one hand, and Sec6l and
TRAM making the translocation machinery itself on
the other hand. This process confers VIP21-caveolin
the following and unusual topology: the hydrophobic
domain is anchored in the membrane in a loop con-
figuration exposing both its N- and C-flanking regions
to the cytoplasmic surface of the microsomes, as al-
ready suggested by immunofluorescence studies (Du-
pree et al., 1993). The hairpin structure could be altered
by changing the whole N-region located upstream
from the anchor of VIP by a sequence of a similar size
deriving from the GH sequence: this fusion protein,
GSAGH-HSCVIP, adopted the type I membrane pro-
tein orientation. This indicates that the hydrophobic
domain and the C terminal tail of the protein are not
sufficient to confer VIP21-caveolin the correct orienta-
Figure 8. The post-translational formation of VIP21-caveolin com-
plex does not involve a vesicle fusion step. WT and TR VIP were
synthesized separately or together in the presence of DPM. In the
post-translational assay the following conditions were included: WT
VIP alone (A), TR VIP alone (B), WT and TR VIP synthesized
together (C), and WT VIP plus TR VIP, previously synthesized
separately in the presence of DPM (D). All four samples were
incubated in the presence of HeLa cytosol. The reaction products
were solubilized at room temperature in the standard SDS-PAGE
sample buffer, and analyzed in the first dimension on a 2.5-7.5%
acrylamide gradient gel. Each lane was cut, boiled in alkaline SDS-
PAGE sample buffer, and analyzed in the second dimension on a
3-16% acrylamide gradient gel. The arrows indicate the WT VIP, the
arrowheads indicate the TR VIP.
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tion and suggests that some structural feature present
in the N domain of the protein is necessary for the
hydrophobic domain to form the loop by which the
native VIP21-caveolin becomes inserted into the mem-
brane. However, our results do not exclude the possi-
bility that VIP21-caveolin does not cross the entire
membrane bilayer but is a monotopic membrane pro-
tein (according to the classification of Blobel, 1980), as
recently demonstrated for the integral membrane pro-
tein, the prostaglandin H2 synthase-1 (Picot et al.,
1994).
The complex formation shows a complete depen-
dence on the presence of membrane-inserted VIP21-
caveolin. No complex could ever be observed when
free VIP21-caveolin, VIP21-caveolin synthesized in the
presence of translocation incompetent membrane
(membrane deleted of SRP), or VIP21-caveolin synthe-
sized before addition of membrane, was used in the
post-translational assay. The proper membrane dispo-
sition of VIP21-caveolin is an essential but not suffi-
cient requirement for the complex formation. Indeed
no complex could be formed by the fusion protein
GSAGH-HSC VIP exposing only the C tail of VIP to
the cytoplasmic surface of the membrane. GSAGH -FL
VIP, which adopts the same topology as the WT VIP,
was not able to generate oligomers in the tested con-
ditions (our unpublished result). Our data also indi-
cate that the first 31 amino acids of the protein have a
strong inhibitory effect on the complex formation, as
shown for the WT VIP low efficiency to form the
oligomers as compared with the TR VIP tested in the
same conditions. The inhibitory role of the N-extrem-
ity might be even exacerbated when an extra amino
acid sequence is added upstream from it, as suggested
by the inability of GSAGH-FL VIP to make complexes.
Moreover, deleted N-terminal sequences consisting of
amino acids 32-80 on the one hand or residues 80-101
on the other hand, linked to the rest of the protein,
were not sufficient to induce VIP21-caveolin oligomer-
ization (our unpublished observations).
The active sequence, including at least a sequence
comprised between amino acids 32 and 101, is under
the control of a cytosolic factor(s) present in two mam-
malian cell lines but not in the plant cytosol, and
which would be involved in mobilizing together the
VIP21-caveolin protein already present in the bilayer.
About 7, 15, or 22 molecules would be found in the
various complexes and modified in such a way that
SDS at room temperature has no access to critical sites
leading to the disruption of these structures. It is im-
portant to note that the in vitro-generated complexes
are not CHAPS insoluble, which is in good agreement
with the fact that insolubility may be linked to the
presence of glycosphingolipids, known to be synthe-
sized in early Golgi. Very little, if any, Golgi-derived
vesicles are present in the dog pancreas microsomes
prepared for the in vitro translocation. This observa-
tion suggests that the complex formation and the ac-
quirement of detergent insolubility are, in the case of
VIP21-caveolin, not simultaneous events.
We propose that the complex formation is a very
early post-translational process, which takes place in
the ER and does not seem to involve vesicle fusion,
but rather the clustering of membrane-inserted VIP21-
caveolin. The detergent insolubility may be linked to
the passage of VIP21-caveolin complex through the
Golgi cisternae or the TGN, where the carrier vesicles
will acquire the detergent insoluble glycosphingolip-
ids (Brown and Rose, 1992; van Meer, 1993, for a
review). However, to date, we have no evidence that
VIP21-caveolin complexes transit through the Golgi
apparatus to the plasma membrane. The complexes
might also acquire their detergent insolubility as they
reach the plasma membrane, directly without passing
through the TGN, by the same carrier vesicles that
may be responsible for the transport of cholesterol
from the ER to the cell membrane (Urbani and Simoni,
1990). The complexes could subsequently be found in
the TGN after internalization of the caveolae as re-
cently described by Parton et al. (1994), or of the caveo-
lin itself as suggested by Smart et al. (1994). This
possibility is, however, not likely because a high con-
tent of cholesterol should confer the CHAPS insolu-
bility to the VIP21-caveolin-containing vesicles ob-
tained in vitro.
Recently published reports have proposed that the
formation of detergent-insoluble oligomers would be
correlated with their retention in the compartment
where this step occurs (Weisz et al., 1993; Schweizer et
al., 1994). The VIP21-caveolin complex we are able to
detect in vitro may correspond to an intermediate step
of the mature, steady-state detergent-insoluble VIP21-
caveolin complex. The possibility to define two steps,
oligomerization and insolubility, may allow us to bet-
ter dissect the processes underlying a membrane pro-
tein processing. Such a multistep process has been
well analyzed for a secretory protein, the von Will-
ebrand factor (Voorberg et al., 1993), which forms di-
sulfide bond-linked dimers in the ER; further process-
ing occurs in the Golgi apparatus where it is found in
the form of high molecular weight multimer. Simi-
larly, trimerization of influenza virus hemagglutinin is
a late ER event necessary for the protein exit from the
ER, and does not lead to detergent insolubility, which
takes place in the late Golgi. Unlike VIP21-caveolin
complex formation, oligomerization or subunit assem-
bly so far characterized involves disulfide bond for-
mation (Braakman et al., 1992), which is an intralumi-
nal reaction probably independent of cytosolic factors.
The assembly processes have been shown to be, at
least partly, under the control of chaperones, which by
an early interaction with either the nascent chain or
the just terminated protein, would prevent the mis-
folding of the protein (see Gething and Sambrook,
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1992), and/or would help in maintaining the proper
disposition which will then be recognized by other
molecules catalyzing proper folding, maturation of a
propeptide, or interaction with other subunits. This
has been shown, for example, for the ER lumen BiP
and the processing of thyroglobulin (Kim et al., 1992),
the 7B2 neuroendocrine chaperone involved in the
secretory pathway (Braks and Martens, 1994), the cy-
tosolic chaperones of the hsp 70 family and their in-
teraction with newly synthesized proteins (Pelham,
1989; Beckmann et al., 1990). A similar process is also
likely to be involved during VIP21-caveolin biosyn-
thesis of the long N terminus, waiting until the rest of
the molecule is available for the SRP interaction and
subsequent membrane incorporation. The formation
of the high molecular weight complexes later made by
the completed VIP21-caveolin is also likely to be
under the control of a chaperone(s) provided by the
cytosol. However, this oligomerization process
probably is of a different nature than the early post-
translational reactions just described for the follow-
ing reasons: 1) the complexes detected in vitro are of
the same size as the "mature" ones detected in vivo;
2) they do not involve disulfide bonds; 3) their
formation is not only ATP hydrolysis and Mg2+
dependent, but also GTP hydrolysis dependent. In
contrast to the oligomerization in the ER of rotavi-
rus proteins (Poruchynsky et al., 1991), VIP21-caveo-
lin complex formation is calcium independent. In
addition, the complexes form exclusively from the
native VIP21-caveolin and from the smaller isoform
lacking the first 31 residues. All these observations
render it very unlikely that VIP21-caveolin oli-
gomers represent the multimolecular complexes or
aggregates observed in the ER, made of terminally
misfolded proteins, and on the way to an active
conformation or to accelerated proteolysis. It is
noteworthy that a member of the hsp70 family, the
uncoating enzyme, hydrolyses ATP in a clathrin-de-
pendent manner, driving disassembly of the clathrin
coat (Ungewickell, 1985). A similar assembly/disas-
sembly of the caveolar coat may also occur under the
control of a specific cytosolic chaperone(s) interacting
either with the caveolar coat to disassemble it or with
the membrane-inserted VIP21-caveolin to promote as-
sembly. Identification of the factor(s) involved in oli-
gomerization should give important information
about the mechanism of the caveolar coat formation.
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